Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits - PubMed (original) (raw)

Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits

S Meterissian et al. Clin Exp Metastasis. 1993 Mar.

Abstract

The liver is the most common site of hematogenous metastases from colorectal carcinoma. Kupffer cells (KC), which line the hepatic sinusoids, may form the first line of defense against circulating tumor cells. The purpose of this study was to determine the effect of hepatic metastases and intra-abdominal tumor growth on KC binding of human colorectal carcinoma (HCRC) cells. MIP-101, a poorly metastatic cell line, and CX-1, a highly metastatic cell line, were injected intrasplenically into nude mice and KC were isolated by collagenase perfusion at varying intervals after injection. Conditioned media were collected from MIP-101, CCL 188 and CX-1 to determine their in vitro effect on KC function. KC from MIP-101 injected mice (14% liver metastases, 100% splenic tumors) bound a significantly greater number of MIP-101 and clone A cells than CX-1 cells in vitro. KC isolated from mice 5 weeks after CX-1 injection (100% liver metastases) also showed increased binding of MIP-101 and clone A cells compared to CX-1 cells. Similar results were obtained when tumor cell binding to normal human liver KC was compared to binding to KC from human livers from patients with hepatic metastasis from colorectal cancer. In contrast KC obtained from mice 3 weeks after CX-1 injection (44% liver metastases) showed significantly decreased binding of MIP-101 and clone A cells. The conditioned medium from CX-1 cells significantly decreased the in vitro binding of both MIP-101 and CX-1 by KC. These results indicate that the ability of KC to bind HCRC cells (which precedes phagocytosis and tumor cell killing) is a dynamic function and affected by concomitant tumor growth. HCRC cells may alter KC function via the production of specific tumor-derived soluble factors. In order to devise new and more effective therapeutic options in the treatment of liver metastases the nature of this tumor cell-KC interaction must be better understood.

PubMed Disclaimer

Similar articles

• Desialylation of metastatic human colorectal carcinoma cells facilitates binding to Kupffer cells.
  Petrick AT, Meterissian S, Steele G Jr, Thomas P. Petrick AT, et al. Clin Exp Metastasis. 1994 Mar;12(2):108-16. doi: 10.1007/BF01753977. Clin Exp Metastasis. 1994. PMID: 8306524
• Kupffer cell/tumor cell interactions and hepatic metastasis in colorectal cancer.
  Meterissian SH, Toth CA, Steele G Jr, Thomas P. Meterissian SH, et al. Cancer Lett. 1994 Jun 15;81(1):5-12. doi: 10.1016/0304-3835(94)90157-0. Cancer Lett. 1994. PMID: 7517341
• Hepatic colorectal cancer metastases: imaging initial steps of formation in mice.
  Kruskal JB, Azouz A, Korideck H, El-Hallak M, Robson SC, Thomas P, Goldberg SN. Kruskal JB, et al. Radiology. 2007 Jun;243(3):703-11. doi: 10.1148/radiol.2432060604. Epub 2007 Apr 12. Radiology. 2007. PMID: 17431127
• Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth.
  van der Bij GJ, Oosterling SJ, Meijer S, Beelen RH, van Egmond M. van der Bij GJ, et al. Immunobiology. 2005;210(2-4):259-65. doi: 10.1016/j.imbio.2005.05.020. Immunobiology. 2005. PMID: 16164033 Review.
• Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity.
  Phillips NC. Phillips NC. Cancer Metastasis Rev. 1989 Dec;8(3):231-52. doi: 10.1007/BF00047339. Cancer Metastasis Rev. 1989. PMID: 2697472 Review.

Cited by

• Desialylation of metastatic human colorectal carcinoma cells facilitates binding to Kupffer cells.
  Petrick AT, Meterissian S, Steele G Jr, Thomas P. Petrick AT, et al. Clin Exp Metastasis. 1994 Mar;12(2):108-16. doi: 10.1007/BF01753977. Clin Exp Metastasis. 1994. PMID: 8306524
• NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.
  Wilmanski JM, Petnicki-Ocwieja T, Kobayashi KS. Wilmanski JM, et al. J Leukoc Biol. 2008 Jan;83(1):13-30. doi: 10.1189/jlb.0607402. Epub 2007 Sep 17. J Leukoc Biol. 2008. PMID: 17875812 Free PMC article. Review.
• Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis.
  Khatib AM, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, Meterissian S, Brodt P. Khatib AM, et al. Am J Pathol. 2005 Sep;167(3):749-59. doi: 10.1016/S0002-9440(10)62048-2. Am J Pathol. 2005. PMID: 16127154 Free PMC article.
• The diverse roles of the TNF axis in cancer progression and metastasis.
  Ham B, Fernandez MC, D'Costa Z, Brodt P. Ham B, et al. Trends Cancer Res. 2016 Jan 1;11(1):1-27. Trends Cancer Res. 2016. PMID: 27928197 Free PMC article.

References

1. 1. Cancer Res. 1985 Jan;45(1):392-7 - PubMed
2. 1. Cancer Res. 1987 Dec 15;47(24 Pt 1):6686-91 - PubMed
3. 1. J Leukoc Biol. 1988 Dec;44(6):474-84 - PubMed
4. 1. J Leukoc Biol. 1991 Jan;49(1):8-14 - PubMed
5. 1. Cancer Immunol Immunother. 1989;28(1):54-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer